Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06627335 · ClinicalTrials.gov registry record
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
A clinical trial of Atopic Dermatitis and Pregnancy Related, sponsored by Incyte Corporation.
- Recruiting
- Registry status
- 5,621
- Enrollment target
- 1
- Study location
NCT06627335 is a study of Atopic Dermatitis and Pregnancy Related that is actively recruiting participants, run by Incyte Corporation. The registered enrollment target is 5,621 participants, above the 572-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (883% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06627335, a study of Atopic Dermatitis and Pregnancy Related, is actively recruiting participants, sponsored by Incyte Corporation.
- RECRUITING
- Registry status
- 5,621 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to assess infant outcomes of women with AD who were exposed to ruxolitinib cream during pregnancy compared with a control cohort of women with AD who were exposed to a topical corticosteroid (TCS) during pregnancy.
Conditions Studied
Interventions
- DRUG Ruxolitinib Cream
- DRUG TCS
Study Locations (1)
North Carolina
- Syneos Health (remote site) - Morrisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,621 participants |
| Start Date | 2023-03-27 |
| Est. Completion | 2028-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06627335
The ClinicalTrials.gov registry entry for NCT06627335 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,621 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 572-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (883% higher). The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which Ruxolitinib Cream is the first listed.
NCT06627335 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06627335 about?
NCT06627335 is a clinical study titled "An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis". This study is to assess infant outcomes of women with AD who were exposed to ruxolitinib cream during pregnancy compared with a control cohort of women with AD who were exposed to a topical corticosteroid (TCS) during pregnancy.
What is the current status of trial NCT06627335?
This trial is currently recruiting. The enrollment target is 5,621 participants. The study started on 2023-03-27. Estimated completion is 2028-08-15.
What conditions does trial NCT06627335 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Pregnancy Related.
What interventions are being tested in trial NCT06627335?
The interventions under investigation include: Ruxolitinib Cream (DRUG), TCS (DRUG).
Who is sponsoring clinical trial NCT06627335?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06627335 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry for Systemic Eczema Treatments
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
RECRUITING
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
-
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.